NCT02797457 Medical Economic Evaluation of Bilateral Allograft of Hands and Forearms

Eligibility & Interventions

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 40 participants in total. It began in 2018-10-16 with a primary completion date of 2031-10-16.

Brief Summary

The double amputation of the forearms is a rare handicap that seriously impacts the autonomy and the quality of life of patients, social and familial exclusion, and dependence on third parties for everyday activities. The management of these patients is nearly exclusively through the use of prostheses. Certain patients refuse this solution, or remain penalized by the absence of sensitivity , the lack of precision in movements, and body image issues related to the amputation; the double graft of hands and forearms may, in this circumstance, be the only solution. Since January 2000, date of the first double hand graft, six bilateral grafts of hands have been performed at the Hospices Civils de Lyon. This first study reported the feasibility of the graft. The functional results obtained after the double transplant have allowed patients to recover complete autonomy for everyday activities, at the price of an immunosuppressive treatment. We have found that these very good functional results are maintained over time and, for a certain number of patients, to return to work which is a factor of social integration. The rate of medical complications (metabolic, infectious, oncological), essentially related to the immunosuppressive treatment, is not greater to that found for other types of graft, but are considered as a limiting factor for the development of this strategy. These results are confirmed by international experience that is of the same order. Only a few rare cases of re-amputation have been reported in patients for whom the immunosuppressive treatment was discontinued or following vascular thrombosis. A new study is required to continue this evaluation and to compare double graft to prostheses in terms costs, quality of life, usefulness, satisfaction, autonomy, and social integration. The results of this study will allow the placement of these strategies in the management of patients with double amputation of the hands and forearms.

Eligibility Criteria

Inclusion Criteria: Inclusion criteria common to the 2 groups of patients (allograft group and protheses group): * Adult aged 18 to 60 years * Double amputated of both forearms Transplant eligibility criteria (for allograft group) * Minimum interval between amputation and graft of three months (no maximal delay) * Absence of previous psychiatric history contraindicating the graft and psychological maturity, according to two psychiatrists who have evaluated the patient * No previous history of malignant tumor in remission for less than 5 years * American Society of Anesthesiology (ASA) score ≤ 2 * New York Heart Association (NYHA) grade ≥ 1 * Creatinine clearance ≥ 60 ml/min/1.73m² * Absence of badly controlled sever hypertension Exclusion Criteria: * Mono amputated patients * Malignant tumor or previous history of malignant tumor for which the risk of recurrence at 5 years is greater than 5%

Contact & Investigator

Frequently Asked Questions

Related Trials